PCM Encore LLC Makes New Investment in Cigna Group $CI

PCM Encore LLC bought a new stake in shares of Cigna Group (NYSE:CI) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 2,360 shares of the health services provider’s stock, valued at approximately $651,000.

A number of other institutional investors and hedge funds have also made changes to their positions in CI. Assetmark Inc. raised its stake in shares of Cigna Group by 10.0% during the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after acquiring an additional 5,963 shares in the last quarter. HighTower Advisors LLC boosted its stake in Cigna Group by 402.7% in the second quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock valued at $97,701,000 after acquiring an additional 283,897 shares in the last quarter. Handelsbanken Fonder AB boosted its stake in Cigna Group by 12.1% in the second quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider’s stock valued at $22,833,000 after acquiring an additional 8,960 shares in the last quarter. Victory Capital Management Inc. grew its holdings in Cigna Group by 41.1% in the fourth quarter. Victory Capital Management Inc. now owns 1,348,713 shares of the health services provider’s stock worth $371,206,000 after purchasing an additional 392,978 shares during the last quarter. Finally, TD Asset Management Inc increased its position in shares of Cigna Group by 4.8% during the second quarter. TD Asset Management Inc now owns 249,966 shares of the health services provider’s stock worth $68,911,000 after purchasing an additional 11,471 shares in the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CI has been the subject of several analyst reports. Robert W. Baird set a $362.00 price objective on Cigna Group in a report on Friday, July 31st. Cantor Fitzgerald upped their target price on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft cut Cigna Group from a “buy” rating to a “hold” rating and decreased their price target for the company from $303.00 to $302.00 in a research note on Wednesday, May 20th. Wells Fargo & Company boosted their price target on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Finally, Wolfe Research restated an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a report on Tuesday, June 16th. Fifteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $339.45.

Insider Activity at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider owned 27,256 shares in the company, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 23,012 shares of company stock valued at $6,386,550. 0.60% of the stock is owned by company insiders.

Cigna Group Price Performance

NYSE:CI opened at $274.50 on Friday. The firm’s fifty day moving average is $284.63 and its two-hundred day moving average is $281.41. The firm has a market cap of $72.53 billion, a price-to-earnings ratio of 11.36, a PEG ratio of 0.95 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a one year low of $239.51 and a one year high of $315.47.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The business had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company’s revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the business posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Research analysts expect that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.3%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.